FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Richard Wilder

Research Profile

Procedures

Concepts & Ideas

Chemicals & Drugs

Disorders

Co-author Network

Publications

TOP 3
Prajnan Das; Andrea Ng; Louis S Constine; Ranjana Advani; Christopher Flowers; Jonathan Friedberg; David C Hodgson; Cindy L Schwartz; Richard B Wilder; Lynn D Wilson; Michael J Yunes
ACR Appropriateness Criteria® on Hodgkin's lymphoma-unfavorable clinical stage I and II.
Pei Lin; L Jeffrey Medeiros; Richard B Wilder; L V Abruzzo; John T Manning; Dan Jones
The activation profile of tumour-associated reactive T-cells differs in the nodular and diffuse patterns of lymphocyte predominant Hodgkin's disease.
Gregory M Chronowski; Richard B Wilder; Lawrence B Levy; E Neely Atkinson; Chul Ha; Fredrick B Hagemeister; Ibrahim Barista; Maria A Rodriguez; Andreas H Sarris; Mark A Hess; Fernando Cabanillas; James D Cox
Second malignancies after chemotherapy and radiotherapy for Hodgkin disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Richard Wilder (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Prajnan Das; Andrea Ng; Louis S Constine; Ranjana Advani; Christopher Flowers; Jonathan Friedberg; David C Hodgson; Cindy L Schwartz; Richard B Wilder; Lynn D Wilson; Michael J Yunes
ACR Appropriateness Criteria® on Hodgkin's lymphoma-unfavorable clinical stage I and II.
Journal of the American College of Radiology : JACR 2011;8(5):302-8.
2004: Pei Lin; L Jeffrey Medeiros; Richard B Wilder; L V Abruzzo; John T Manning; Dan Jones
The activation profile of tumour-associated reactive T-cells differs in the nodular and diffuse patterns of lymphocyte predominant Hodgkin's disease.
Histopathology 2004;44(6):561-9.
2004: Gregory M Chronowski; Richard B Wilder; Lawrence B Levy; E Neely Atkinson; Chul Ha; Fredrick B Hagemeister; Ibrahim Barista; Maria A Rodriguez; Andreas H Sarris; Mark A Hess; Fernando Cabanillas; James D Cox
Second malignancies after chemotherapy and radiotherapy for Hodgkin disease.
American journal of clinical oncology 2004;27(1):73-80.
2004: Chul Ha; Ming-Sheng Lee; Peter McLaughlin; Susan L Tucker; Richard B Wilder; James D Cox; Fernando Cabanillas
Molecular response of follicular lymphoma to cyclophosphamide, doxorubicin, vincristine, prednisone C(H)OP or COP-based therapy as measured by polymerase chain reaction evidence of translocation (14;18)(q32;q21).
Cancer journal (Sudbury, Mass.) 2004;10(1):49-53.
2003: Chul Ha; Joseph S Kong; Peter McLaughlin; Susan L Tucker; Luis Fayad; Mark A Hess; Richard B Wilder; Fernando Cabanillas; James D Cox
Stage III follicular lymphoma: long-term follow-up and patterns of failure.
International journal of radiation oncology, biology, physics 2003;57(3):748-54.
2003: Chul Ha; Joseph S Kong; Susan L Tucker; Peter McLaughlin; Richard B Wilder; Mark A Hess; Fernando Cabanillas; James D Cox
Central lymphatic irradiation for stage I-III follicular lymphoma: report from a single-institutional prospective study.
International journal of radiation oncology, biology, physics 2003;57(2):316-20.
2003: Bouthaina S Dabaja; Peter McLaughlin; Chul Ha; Barbara Pro; Christina A Meyers; Lee F Seabrooke; Richard B Wilder; Athanassios P Kyritsis; H Alejandro Preti; W K Alfred Yung; Victor Levin; Fernando Cabanillas; James D Cox
Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy.
Cancer 2003;98(5):1021-8.
2003: James D Cox; Chul Ha; Hoon K Lee; Bouthaina S Dabaja; Richard B Wilder
Uncertainties in contemporary treatment of aggressive lymphomas.
Rays 2003;28(3):289-92.
2003: Bouthaina S Dabaja; Chul Ha; Richard B Wilder; Barbara Pro; Peter McLaughlin; Fernando Cabanillas; James D Cox
Importance of esophagogastroduodenoscopy in the evaluation of non-gastrointestinal mucosa-associated lymphoid tissue lymphoma.
Cancer journal (Sudbury, Mass.) 2003;9(4):321-4.
2003: Steven M Kirsner; Rajat J Kudchadker; Karl Prado; Chul Ha; Richard B Wilder; James D Cox
Clinical implications of incorporating heterogeneity corrections in mantle field irradiation.
International journal of radiation oncology, biology, physics 2003;55(4):1135-42.
2003: Gregory M Chronowski; Richard B Wilder; Susan L Tucker; Chul Ha; Anas Younes; Luis Fayad; Maria A Rodriguez; Fredrick B Hagemeister; Ibrahim Barista; Fernando Cabanillas; James D Cox
Analysis of in-field control and late toxicity for adults with early-stage Hodgkin's disease treated with chemotherapy followed by radiotherapy.
International journal of radiation oncology, biology, physics 2003;55(1):36-43.
2002: Gregory M Chronowski; Richard B Wilder; Susan L Tucker; Chul Ha; Andreas H Sarris; Fredrick B Hagemeister; Ibrahim Barista; Mark A Hess; Fernando Cabanillas; James D Cox
An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease.
Cancer 2002;95(12):2534-8.
2002: Hoon K Lee; Richard B Wilder; Dan Jones; Chul Ha; Barbara Pro; Maria A Rodriguez; Jorge Romaguera; Fernando Cabanillas; Jose Rodriguez; James D Cox
Outcomes using doxorubicin-based chemotherapy with or without radiotherapy for early-stage peripheral T-cell lymphomas.
Leukemia & lymphoma 2002;43(9):1769-75.
2002: Pamela J Schlembach; Richard B Wilder; Dan Jones; Chul Ha; Luis Fayad; Anas Younes; Fredrick Hagemeister; Mark Hess; Fernando Cabanillas; James D Cox
Radiotherapy alone for lymphocyte-predominant Hodgkin's disease.
Cancer journal (Sudbury, Mass.) 2002;8(5):377-83.
2002: Richard B Wilder; Maria A Rodriguez; L Jeffrey Medeiros; Susan L Tucker; Chul Ha; Jorge Romaguera; Barbara Pro; Mark A Hess; Fernando Cabanillas; James D Cox
International prognostic index-based outcomes for diffuse large B-cell lymphomas.
Cancer 2002;94(12):3083-8.
2002: Bouthaina S Dabaja; Chul Ha; Deborah A Thomas; Richard B Wilder; Ramesh Gopal; Jorge Cortes; Carlos E Bueso-Ramos; Mark A Hess; James D Cox; Hagop M Kantarjian
The role of local radiation therapy for mediastinal disease in adults with T-cell lymphoblastic lymphoma.
Cancer 2002;94(10):2738-44.
2002: Richard B Wilder; Pamela J Schlembach; Dan Jones; Gregory M Chronowski; Chul Ha; Anas Younes; Fredrick B Hagemeister; Ibrahim Barista; Fernando Cabanillas; James D Cox
European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte-predominant Hodgkin disease.
Cancer 2002;94(6):1731-8.
2002: Richard B Wilder; Chul Ha; James D Cox; Donna Weber; Kay Delasalle; Raymond Alexanian
Persistence of myeloma protein for more than one year after radiotherapy is an adverse prognostic factor in solitary plasmacytoma of bone.
Cancer 2002;94(5):1532-7.
2002: Richard B Wilder; Jorge Romaguera; Susan L Tucker; Chul Ha; Mark A Hess; Fernando Cabanillas; James D Cox
Results with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone followed by radiotherapy with or without prechemotherapy surgical debulking for patients with bulky, aggressive lymphoma.
Cancer 2002;94(3):601-5.
2001: Richard B Wilder; Dan Jones; Susan L Tucker; Lillian M Fuller; Chul Ha; Peter McLaughlin; Mark A Hess; Fernando Cabanillas; James D Cox
Long-term results with radiotherapy for Stage I-II follicular lymphomas.
International journal of radiation oncology, biology, physics 2001;51(5):1219-27.
2001: James D Cox; Chul Ha; Richard B Wilder
Radiation therapy for malignant lymphoma: enduring importance in the era of systemic therapy.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2001;55(9-10):516-8.
2001: R H Chou; Richard B Wilder; Michael S Wong; K M Forster
Recent advances in radiotherapy for head and neck cancers.
Ear, nose, & throat journal 2001;80(10):704-7, 711-4, 716 passim.
2001: Chul Ha; Susan L Tucker; Angel I Blanco; Richard B Wilder; Peter McLaughlin; Fernando Cabanillas; James D Cox
Hematologic recovery after central lymphatic irradiation for patients with stage I-III follicular lymphoma.
Cancer 2001;92(5):1074-9.
2001: Gregory M Chronowski; Chul Ha; Richard B Wilder; Fernando Cabanillas; J Manning; James D Cox
Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy.
Cancer 2001;92(3):670-6.
2001: Richard B Wilder; Maria A Rodriguez; Susan L Tucker; Chul Ha; Mark A Hess; Fernando Cabanillas; James D Cox
Radiation therapy after a partial response to CHOP chemotherapy for aggressive lymphomas.
International journal of radiation oncology, biology, physics 2001;50(3):743-9.
2001: Richard B Wilder; Maria A Rodriguez; Chul Ha; Barbara Pro; Mark A Hess; Fernando Cabanillas; James D Cox
Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphoma.
Cancer 2001;91(12):2440-6.
2001: Christopher E Pelloski; Richard B Wilder; Chul Ha; Mark A Hess; Fernando Cabanillas; James D Cox
Clinical stage IEA-IIEA orbital lymphomas: outcomes in the era of modern staging and treatment.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2001;59(2):145-51.
2001: Chul Ha; K M Shadle; L Jeffrey Medeiros; Richard B Wilder; Mark A Hess; Fernando Cabanillas; James D Cox
Localized non-Hodgkin lymphoma involving the thyroid gland.
Cancer 2001;91(4):629-35.
2001: Richard B Wilder; Susan L Tucker; Chul Ha; Maria A Rodriguez; Mark A Hess; Fernando Cabanillas; James D Cox
Dose-response analysis for radiotherapy delivered to patients with intermediate-grade and large-cell immunoblastic lymphomas that have completely responded to CHOP-based induction chemotherapy.
International journal of radiation oncology, biology, physics 2001;49(1):17-22.
2000: Pamela J Schlembach; Richard B Wilder; Susan L Tucker; Chul Ha; Maria A Rodriguez; Mark A Hess; Fernando Cabanillas; James D Cox
Impact of involved field radiotherapy after CHOP-based chemotherapy on stage III-IV, intermediate grade and large-cell immunoblastic lymphomas.
International journal of radiation oncology, biology, physics 2000;48(4):1107-10.
2000: Richard B Wilder; R H Chou; J K Ryu; R L Stern; Michael S Wong; M Ji; M Roach; Ralph W deVere White
Potency preservation after three-dimensional conformal radiotherapy for prostate cancer: preliminary results.
American journal of clinical oncology 2000;23(4):330-3.
2000: Richard B Wilder; J Y Hsiang; M Ji; John D Earle; Ralph W deVere White
Preliminary results of three-dimensional conformal radiotherapy as salvage treatment for a rising prostate-specific antigen level postprostatectomy.
American journal of clinical oncology 2000;23(2):176-80.
2000: R H Chou; Richard B Wilder; M Ji; Janice K Ryu; BR Leigh; John D Earle; R L Doggett; HD Kubo; Mack Roach; Ralph W deVere White
Acute toxicity of three-dimensional conformal radiotherapy in prostate cancer patients eligible for implant monotherapy.
International journal of radiation oncology, biology, physics 2000;47(1):115-9.
1999: HD Kubo; Richard B Wilder; C T Pappas
Impact of collimator leaf width on stereotactic radiosurgery and 3D conformal radiotherapy treatment plans.
International journal of radiation oncology, biology, physics 1999;44(4):937-45.
1998: S K Seung; Stewart Kroll; Richard B Wilder; MD Posner; Mack Roach
Candidates for prostate radioactive seed implantation treated by external beam radiotherapy.
The cancer journal from Scientific American 1998;4(3):168-74.
1997: H D Kubo; C T Pappas; Richard B Wilder
A comparison of arc-based and static mini-multileaf collimator-based radiosurgery treatment plans.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1997;45(1):89-93.
1997: Richard B Wilder; P D Fone; D E Rademacher; C D Jones; Mack Roach; John D Earle; Ralph W deVere White
Localization of the prostatic apex for radiotherapy treatment planning using urethroscopy.
International journal of radiation oncology, biology, physics 1997;38(4):737-41.
1996: Richard B Wilder; Gerald L DeNardo; Sui Shen; J F Fowler; Barry W Wessels; Sally J DeNardo
Application of the linear-quadratic model to myelotoxicity associated with radioimmunotherapy.
European journal of nuclear medicine 1996;23(8):953-7.
1996: Richard B Wilder; Gerald L DeNardo; Sally J DeNardo
Radioimmunotherapy: recent results and future directions.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(4):1383-400.
1992: Richard B Wilder; John M. Buatti; J M Kittelson; D S Shimm; Paul M Harari; E E Rogoff; J R Cassady
Pterygium treated with excision and postoperative beta irradiation.
International journal of radiation oncology, biology, physics 1992;23(3):533-7.
1991: Richard B Wilder; J M Kittelson; D S Shimm
Basal cell carcinoma treated with radiation therapy.
Cancer 1991;68(10):2134-7.
1991: Richard B Wilder; D S Shimm; J M Kittelson; E E Rogoff; J R Cassady
Recurrent basal cell carcinoma treated with radiation therapy.
Archives of dermatology 1991;127(11):1668-72.
1991: D S Shimm; Richard B Wilder
Radiation therapy for squamous cell carcinoma of the skin.
American journal of clinical oncology 1991;14(5):383-6.
1991: Richard B Wilder; Paul M Harari; A R Graham; D S Shimm; J R Cassady
Merkel cell carcinoma. Improved locoregional control with postoperative radiation therapy.
Cancer 1991;68(5):1004-8.